Fulltext

Practice of ultrasound-guided arthrocentesis and joint injection, including training and implementation, in Europe: results of a survey of experts and scientific societies

Mandl, Peter ; Naredo, Esperanza ; Conaghan, Philip G. ; D'Agostino, Maria-Antonietta ; Wakefield, Richard J. ; Bachta, Artur ; Backhaus, Marina ; Hammer, Hilde B. ; Bruyn, George A. W. ; Damjanov, Nemanja ; Filippucci, Emilio ; Grassi, Walter ; Iagnocco, Annamaria ; Jousse-Joulin, Sandrine ; Kane, David ; Koski, Juhani M. ; Möller, Ingrid ; De Miguel, Eugenio ; Schmidt, Wolfgang A. ; Swen, Wijnand A. A. ; Szkudlarek, Marcin ; Terslev, Lene ; Ziswiler, Hans-Rudolf ; Østergaard, Mikkel ; Balint, Peter V.

In: Rheumatology, 2012, vol. 51, no. 1, p. 184-190

Aggiungi alla tua lista
    Titre
    • Practice of ultrasound-guided arthrocentesis and joint injection, including training and implementation, in Europe: results of a survey of experts and scientific societies
    Auteur
    • Mandl, Peter. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Naredo, Esperanza. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Conaghan, Philip G.. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • D'Agostino, Maria-Antonietta. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Wakefield, Richard J.. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Bachta, Artur. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Backhaus, Marina. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Hammer, Hilde B.. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Bruyn, George A. W.. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Damjanov, Nemanja. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Filippucci, Emilio. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Grassi, Walter. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Iagnocco, Annamaria. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Jousse-Joulin, Sandrine. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Kane, David. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Koski, Juhani M.. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Möller, Ingrid. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • De Miguel, Eugenio. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Schmidt, Wolfgang A.. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Swen, Wijnand A. A.. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Szkudlarek, Marcin. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Terslev, Lene. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Ziswiler, Hans-Rudolf. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Østergaard, Mikkel. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    • Balint, Peter V.. 3rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain, Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Leeds, UK, Department of Rheumatology, Université de Versailles St-Quentin-en Yvelines, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, Paris, France, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warsaw, Poland, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, Department of Rheumatology, MC IJsselmeerziekenhuizen, Lelystad, The Netherlands, Institute of Rheumatology, Belgrade, Serbia, Department of Rheumatology, Universitá Politecnica delle Marche, Ancona, Italy, Department of Rheumatology, Sapienza University, Rome, Italy, Department of Rheumatology, CHU Cavale Blanche, Brest, France, Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin, Ireland, Department of Rheumatology, Mikkeli Central Hospital, Mikkeli, Finland, Instituto Poal de Reumatologia-Hospital Platon, Barcelona, Rheumatology Unit, La Paz University Hospital, Madrid, Spain, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, Department of Rheumatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands, Department of Rheumatology, University of Copenhagen Hospital at Køge, Køge, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology/Allergy, Inselspital, University Hospital, Bern, Switzerland.
    Type de document
    • Postprint
    Identifiant OAI-PMH
    • oai:doc.rero.ch:298452
    Summary
    Objectives. To document the practice and training opportunities of US-guided arthrocentesis and joint injection (UGAJ) among rheumatologists in the member countries of the European League Against Rheumatism (EULAR). Methods. An English-language questionnaire, containing questions on demographics, clinical and practical aspects of UGAJ, training options in UGAJ for rheumatologists, UGAJ education in the rheumatology training curriculum and other structured education programmes in UGAJ was sent to three different groups: (i) all national rheumatology societies of EULAR; (ii) all national societies of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB); and (iii) 22 senior rheumatologists involved in EULAR musculoskeletal US training from 14 European countries, who were also asked to circulate the questionnaire among relevant colleagues. Results. Thirty-three (75%) of 44 countries responded to the questionnaire (61.3% of national rheumatology societies, 25% of the national US societies and 100% of expert ultrasonographers). In the majority of countries (85%) <10% of rheumatologists routinely perform UGAJ in clinical practice, while the remaining countries (15%) reported a rate of 10-50%. The percentage of rheumatologists receiving training in UGAJ was <10% in the majority (72.7%) of countries. Conclusion. The study highlights the relatively low prevalence of UGAJ as compared with the high (>80%) rate of rheumatologists performing conventional joint injection in most of the surveyed countries. The reported variations in practice and the lack of available structured training programmes for trainees in most countries indicates the need for standardization in areas including training guidelines